Cargando…
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
BACKGROUND: Hyperuricemia and gout are a group of disorders of purine metabolism. In recent years, the incidence of hyperuricemia and gout has been increasing, which is a severe threat to people’s health. Several studies on hyperuricemia and gout in proteomics and metabolomics have been conducted re...
Autores principales: | Wu, Xinghong, You, Chongge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828291/ https://www.ncbi.nlm.nih.gov/pubmed/36632144 http://dx.doi.org/10.7717/peerj.14554 |
Ejemplares similares
-
The regulatory roles and mechanisms of the transcription factor FOXF2 in human diseases
por: Wu, Qiong, et al.
Publicado: (2021) -
Susceptibility genes of hyperuricemia and gout
por: Nian, Yue-Li, et al.
Publicado: (2022) -
Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009) -
Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023) -
Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms
por: Zhao, Jianan, et al.
Publicado: (2022)